Skip to content

A randomised trial of propofol sedation versus desflurane anaesthesia, used to supplement spinal anaesthesia, on the quality of recovery following hip replacement surgery in adult patients

A randomised trial of propofol sedation versus desflurane anaesthesia, used to supplement spinal anaesthesia, on the quality of recovery following hip replacement surgery in adult patients

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000805774
Enrollment
52
Registered
2013-07-22
Start date
2013-09-02
Completion date
2016-04-04
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study aims to assess whether two different anaesthetic techniques can affect the postoperative quality of recovery in patients undergoing total hip replacement surgery. The two techniques are considered as sedation or light general anaesthesia as they supplement a spinal anaesthetic - which is the primary anaesthetic technique for these patients. The quality of recovery is measured using a scale called the PQRS, which measures recovery in a number of different domains and compares recovery to the patients pre-surgery values.

Interventions

For patients receiving propofol infusion, the dose will be adjusted according to sedation requirements by the anaesthetist (This may range fom 50-500 mg/hr via intravenous infusion). Patients will be spontaneously ventilating, with supplemental oxygen administered via a clear Hudson mask at 6 L /min. Supplemental midazolam (1-5 mg intravenous) is permitted. A BIS target of > 65 will be set for depth of sedation. For patients receiving desflurane anesthesia they will receive intravenous inducti

For patients receiving propofol infusion, the dose will be adjusted according to sedation requirements by the anaesthetist (This may range fom 50-500 mg/hr via intravenous infusion). Patients will be spontaneously ventilating, with supplemental oxygen administered via a clear Hudson mask at 6 L /min. Supplemental midazolam (1-5 mg intravenous) is permitted. A BIS target of > 65 will be set for depth of sedation. For patients receiving desflurane anesthesia they will receive intravenous induction of anesthesia with propofol (50-200 mg) followed by desflurane via inhalation. Ventilation will be via larangeal mask anesthesia and spontaneous ventilation unless the treating anaesthetist considers that endotracheal intubation and mechanical ventilation is required for the particular patient. The dose of desflurane will be adjusted according to the clinical requirement by the anaesthetist. A target BIS of 40-60 will be set for depth of anaesthesia.

Sponsors

The University of Melbourne
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult patients undergoing hip replacement surgery under spinal anesthesia

Exclusion criteria

Patients, who are not fluent in English will be excluded, as they may be unable to answer the recovery questionnaire adequately. Patients where either general or regional anesthesia is contraindicated, will be excluded

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026